Publications by authors named "Takumi Sugai"
Arch Osteoporos
November 2023
Article Synopsis
- - The ACTIVE-J trial demonstrated that daily subcutaneous injections of 80 μg abaloparatide significantly increased bone mineral density (BMD) in Japanese patients with osteoporosis at high fracture risk.
- - An analysis of hip geometry and biomechanical properties using dual-energy X-ray absorptiometry (DEXA) scans showed substantial improvements in various bone structural parameters after 78 weeks of abaloparatide treatment compared to placebo.
- - Key findings included increased cortical thickness and volumetric BMD at the hip, alongside a reduced buckling ratio, indicating a lower risk of fractures and reinforcing the potential benefits of abaloparatide for osteoporosis management.
